Silva Sepyan

Mental Health Counselor


  600 W Broadway, Suite 315, Glendale
     California, 91204-1022
  818-288-3460    Maps & Directions
Silva Sepyan is a Glendale, California based counselor who is specialized as Mental Health Counselor. Her current practice location is 600 W Broadway, Suite 315, Glendale. Patients can book an appointment with her at 818-288-3460.
Silva Sepyan is a licensed professional who helps individuals, couples, and families manage and overcome emotional, psychological, and behavioral challenges. She assess clients’ mental health conditions and develop personalized treatment plans to provide therapy for a range of mental health issues, including anxiety, depression, trauma, relationship issues, stress, grief, and life transitions.
Complete Profile:
Silva Sepyan speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Silva Sepyan
Specialization: Mental Health Counselor
Gender:Female
Accepts Medicare Assignment:No
Practice Address:600 W Broadway, Suite 315, Glendale,
California, 91204-1022
Phone:818-288-3460
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1124472634
NPI Enumeration Date: 20 Apr, 2016
NPI Last Update On: 20 Apr, 2016

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 1217 N Kingsley Dr Apt 8,
Los Angeles, California
Zip: 90029-1327
Phone Number: 323-445-1874
Patients can reach Silva Sepyan at 600 W Broadway, Suite 315, Glendale, California or can call to book an appointment on 818-288-3460.
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.

Comments/ Reviews: